News | Coronavirus (COVID-19) | June 18, 2020

 

Researchers from five infectious disease hospitals across four districts in Guangzhou, China found that the less pulmonary consolidation on chest CT, the greater the possibility of negative initial reverse transcription–polymerase chain reaction (RT-PCR) results for 21 patients (nine men, 12 women; age range, 26–90 years)

Researchers from five infectious disease hospitals across four districts in Guangzhou, China found that the less pulmonary consolidation on chest CT, the greater the possibility of negative initial reverse transcription–polymerase chain reaction (RT-PCR) results for 21 patients (nine men, 12 women; age range, 26–90 years)

Comparison of CT features between groups with negative and positive initial RT-PCR results.
aThe difference was statistically significant in comparison of the two groups (p < 0.05).


June 18, 2020 — An open-access American Journal of Roentgenology (AJR) article exploring the diagnostic value of chest computed tomography (CT)  for coronavirus disease (COVID-19) pneumonia — especially for patients with negative initial results of reverse transcription–polymerase chain reaction (RT-PCR) testing — found that the less pulmonary consolidation on chest CT, the greater the possibility of negative initial RT-PCR results.

From January 19 to February 20, 2020, lead investigator Dandan Chen of Guangzhou First People’s Hospital in China obtained the admission data of 21 patients (nine men, 12 women; age range, 26–90 years) with confirmed COVID-19 pneumonia from five nonspecialized infectious disease hospitals across Guangzhou.

After undergoing chest CT and swab RT-PCR tests within 3 days, patients were divided into two groups: seven patients with negative initial results (who were found to have positive results after a second RT-PCR test 2 days later) and 14 patients with initial positive results.

“Most of the COVID-19 lesions were located in multiple lobes (67%) in both lungs (72%) in our study,” Chen et al. wrote, adding that the CT findings observed most frequently were ground-glass opacities (95%) and consolidation (72%) with subpleural distribution (100%). “Otherwise,” they continued, “33% of patients had other lesions around the bronchovascular bundle.”

Additional chest CT findings identified by Chen and colleagues included air bronchogram (57%), vascular enlargement (67%), interlobular septal thickening (62%), and pleural effusions (19%).

Ultimately, compared with the positive initial RT-PCR results group, CT of the group with negative initial RT-PCR results was less likely to indicate pulmonary consolidation (p < 0.05).

Acknowledging that RT-PCR detection can be affected by laboratory reagents, test method, and subjective operability, Chen noted that, theoretically, the multicenter nature of this study—five hospitals in four districts of Guangzhou (13 cases in Huadu, four in Baiyun, three in Yuexiu, one in Nansha)—should have reduced interference by such factors.
“When patients with suspected COVID-19 pneumonia who have an epidemiologic history and typical CT features have negative initial RT-PCR results,” the authors of this AJR article concluded, “repeated RT-PCR tests and patient isolation should be considered.”

For more information: www.ajronline.com


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | Cardiac Imaging

February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image ...

Time February 28, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 28, 2024 — Royal Philips, a global leader in health technology, today announced a significant milestone as it ...

Time February 28, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — Median Technologies announced that the Company will be participating and speaking at the premier ...

Time February 27, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it’s ...

Time February 27, 2024
arrow
News | X-Ray

February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the ...

Time February 26, 2024
arrow
News | Artificial Intelligence

February 26, 2024 — DeepHealth, Inc., one of the leading providers in healthcare radiology informatics, has today ...

Time February 26, 2024
arrow
News | PACS

February 22, 2024 — aycan, a recognized leader in medical imaging, announced that Enspectra Health used aycan’s PACS ...

Time February 22, 2024
arrow
Subscribe Now